Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting

Publication | Closed Access

DOI

191

Citations

References

2011

Year

Giorgio Guazzoni, Luciano Nava, Massimo Lazzeri, Vincenzo Scattoni, Giovanni Lughezzani, Carmen Maccagnano, Fernanda Dorigatti, Ferruccio Ceriotti, Marina Pontillo, Vittorio Bini,

European Urology

UrologyGenitourinary CancerMedicinePathologyProspective StudyProstatic DiseaseOncologyProstate-specific Antigen